On Jan. 6, the Senate confirmed Sara Carter as director of the White House Office of National Drug Control Policy by a 52-48 vote. As “drug czar,” Carter will have a major role in shaping the administration’s drug policy agenda amid a push to address several issues, including substance use prevention, treatment and recovery.